Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

Plain-English summary

Apollo Care, LLC is voluntarily recalling 24,608 vials of Semaglutide 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vials. The recall is due to the presence of particulate matter, which has been identified as nylon/polyamide and silk/proteinaceous-type material. The affected product is distributed nationwide within the U.S.

The recall includes vials with the following lot numbers and expiration dates: AC-017125 (Exp. 8/30/2026); AC-017138, AC-017147, AC-017214, AC-017226, and AC-017228 (Exp. 12/31/2026). The product is prescription-only and intended for subcutaneous injection.

Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be discontinued and returned to the supplier or disposed of according to local regulations. Patients should contact their healthcare provider for alternative treatment options if they have been using the affected product.

The recalled product

Product

SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02

Manufacturer

Apollo Care, LLC

Category

Drug — Injectable Medication

Hazard

• particulate-matter
• foreign-object

Affected units

24,608

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls